Provided by Tiger Fintech (Singapore) Pte. Ltd.

CASI Pharmaceuticals

1.30
-0.0500-3.72%
Post-market: 1.24-0.0550-4.25%19:21 EDT
Volume:28.23K
Turnover:36.57K
Market Cap:20.06M
PE:-0.51
High:1.35
Open:1.35
Low:1.27
Close:1.35
Loading ...

CASI Pharmaceuticals Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
19 May

CASI Pharmaceuticals: Strategic Divestments and Promising Clinical Developments Drive Buy Rating

TIPRANKS
·
19 May

CASI Pharmaceuticals Q1 EPS $(0.69) Misses $(0.61) Estimate, Sales $6.24M Beat $6.10M Estimate

Benzinga
·
17 May

CASI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May

CASI Pharmaceuticals Reports 82% Surge in Q1 2025 Revenues; Net Loss Widens by 14%

Reuters
·
16 May

BRIEF-CASI Pharmaceuticals Inc Daniel Lang To Step Down From His Role As Co’S Chief Financial Officer

Reuters
·
15 May

CASI Pharmaceuticals: Deanna Qian to Assume Role of CFO While Retaining Position as Global Controller of Co

THOMSON REUTERS
·
15 May

CASI Pharmaceuticals Inc: Daniel Lang to Step Down From His Role as Co’s Chief Financial Officer

THOMSON REUTERS
·
15 May

CASI Pharmaceuticals Inc expected to post a loss of 61 cents a share - Earnings Preview

Reuters
·
14 May

CASI to Divest Two Subsidiaries in China

MT Newswires Live
·
12 May

CASI Pharmaceuticals Divests Chinese Assets in $20 Million Deal

TIPRANKS
·
12 May

CASI Pharmaceuticals Inc expected to post a loss of 61 cents a share - Earnings Preview

Reuters
·
09 May

CASI Pharmaceuticals Faces Nasdaq Compliance Challenge

TIPRANKS
·
07 May

CASI Pharmaceuticals-Discontinuance of New York Litigation Proceeding & Demand for Arbitration With Respect to Dispute With Acrotech

THOMSON REUTERS
·
09 Apr

CASI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
09 Apr

CASI Pharmaceuticals. Inc. : H.c. Wainwright Cuts Target Price to $4 From $6

THOMSON REUTERS
·
09 Apr

CASI Pharmaceuticals Acquires Precision Autoimmune Therapeutics

TIPRANKS
·
04 Apr

BRIEF-Casi Pharmaceuticals Signs Agreement To Acquire Equity Interests In Precision Autoimmune Therapeutics

Reuters
·
04 Apr

CASI Pharmaceuticals Inc: Signs Agreement to Acquire Equity Interests in Precision Autoimmune Therapeutics

THOMSON REUTERS
·
04 Apr

Casi Receives Updated Proposal From Chairman to Acquire China Business; Shares Rise

MT Newswires Live
·
03 Apr